White paperThe Enterprise Framework for Compliant, Scalable AI
Download now
← About USDM

USDM Subject Matter Expert

Jay Crowley

VP, Medical Device Solutions and Services

Former FDA leader and globally recognized UDI expert helping medical device manufacturers navigate global UDI, EUDAMED, MDR/IVDR, GUDID, medical device data, and regulatory compliance complexity.

Jay Crowley medical device UDI expert featured image

Why Jay matters

Jay helped develop the framework and authored key requirements for FDA's Unique Device Identification system after 26 years at FDA, including leadership roles connected to patient safety, compliance, and the Center for Devices and Radiological Health.

26 years

FDA experience

Roles spanning design controls, compliance, patient safety, adverse event reporting, and FDA leadership offices.

UDI

Framework authority

Helped develop the framework and authored key requirements for FDA's Unique Device Identification system.

CDRH

Patient safety

Served as Senior Advisor for Patient Safety in FDA's Center for Devices and Radiological Health.

Global

Regulatory scope

Guides UDI, GUDID, EUDAMED, MDR/IVDR, and emerging regional medical device data requirements.

Profile

Medical device regulatory guidance from someone who helped shape UDI.

Jay Crowley is USDM's Vice President of Medical Device Solutions and Services and one of the industry's most recognized authorities on Unique Device Identification (UDI). He works with medical device manufacturers that need to turn global regulatory requirements into executable strategies across data, labeling, systems, and operations.

Before joining USDM, Jay spent 26 years at the U.S. Food and Drug Administration, where he held roles connected to design control regulations, patient safety, adverse event reporting, the Office of the Commissioner, the Office of Compliance, and the FDA's Center for Devices and Radiological Health.

Jay helped develop the framework and authored key requirements for FDA's UDI system. That background gives USDM clients practical guidance on how regulators think, where implementation programs often break down, and how to build a defensible approach before deadlines or inspections create urgency.

At USDM, Jay advises medical device companies on global UDI strategy, MDR/IVDR and EUDAMED readiness, GUDID compliance, master data management, database submission planning, and the cross-functional operating model required to keep product data accurate across markets.

What Jay helps solve

From regulatory ambiguity to executable UDI programs.

Medical device UDI work breaks down when regulatory requirements, product data, labeling, systems, and ownership are treated as separate problems. Jay helps teams make them one program.

Global UDI strategy and policy

Build a UDI program that works across product portfolios, regions, and enterprise systems instead of reacting country by country.

  • Corporate UDI strategy
  • Enterprise implementation plans
  • Portfolio-level regulatory mapping

FDA UDI and GUDID compliance

Translate FDA expectations into practical data, labeling, and submission controls that can stand up to scrutiny.

  • GUDID data readiness
  • Labeling and direct marking considerations
  • Inspection-ready evidence
Read related insight

EU MDR / IVDR and EUDAMED readiness

Prepare for EUDAMED obligations with clear ownership, data quality, actor/module planning, and operational readiness.

  • MDR and IVDR UDI requirements
  • EUDAMED submission planning
  • Deadline and readiness assessment
Read related insight

Medical device master data management

Connect regulatory requirements to the product data model, governance process, and system interfaces that keep submissions accurate.

  • Product data governance
  • Master data plans
  • Interface and submission mapping

Global database submission planning

Plan for GUDID, EUDAMED, and regional UDI databases with fewer surprises and cleaner cross-functional handoffs.

  • Submission workflows
  • Regional data requirements
  • Exception and lifecycle controls

Regulatory operating model alignment

Bring RA, QA, IT, labeling, supply chain, and data owners into one implementation path with clear decision rights.

  • Stakeholder alignment
  • Governance model design
  • Program oversight

Client outcomes

Make global UDI compliance manageable instead of reactive.

USDM helps medical device teams align strategy, systems, data, labeling, and accountability so regulatory requirements can be executed and defended.

Build global UDI strategy, policy, and implementation roadmaps.

Establish enterprise-wide UDI programs mapped to complex product portfolios.

Align regulatory affairs, quality, IT, labeling, supply chain, and master data teams.

Develop master data management plans that support global UDI submission requirements.

Prepare for EUDAMED, GUDID, and emerging regional UDI databases.

Clarify edge cases across kits, accessories, software, direct marking, discontinued products, and regional differences.

Support strategic partnerships and solution-selection work for UDI implementation.

UDI guidance library

Practical guidance for UDI, EUDAMED, MDR/IVDR, and medical device data decisions.

Use these resources to plan requirements, prepare submissions, align product data owners, and avoid last-minute compliance surprises.

View more guidance
Webinar

EUDAMED Has Landed – What It Means for You, Now

Watch Jay Crowley explain what the EUDAMED mandatory-use milestone means for MDR/IVDR compliance, UDI data readiness, and medical device operating models.

Read insight
Blog

EUDAMED Compliance: Your Most Pressing Questions—Answered

Get expert answers to top EUDAMED compliance questions and learn how to avoid costly registration pitfalls before the 2026 deadline.

Read insight
Webinar

EUDAMED Challenges for Medical Device Manufacturers: Future-Proof Your 2025 Compliance Strategy

Discover how to streamline EUDAMED compliance and UDI registration. Learn from USDM & BYRD Health before the 2026 deadlines hit.

Read insight
Blog

Q&A: Mandatory Use of EUDAMED Now Starting Q1 2026

Jay Crowley and Lionel Tussau help make medical device manufacturers aware of key dates, requirements, and regulatory implications.

Read insight
Webinar

Mandatory Use of EUDAMED Now Starting Q1 2026

Technical considerations and guidance for managing UDI data to meet the deadline. Learn more in this webinar!

Read insight
Webinar

An Update on the FDA’s UDI and GUDID Compliance Requirements

ON-DEMAND WEBINAR: An update on the FDA’s requirements and notification activities and aims to answer many of the incoming questions our UDI consultants have received recently.

Read insight
Webinar

Global UDI Data Management – The New Paradigm

Currently, multiple regulators have or are launching national UDI Databases (US, EU, SFDA, NMPA, KFDA, HSA). Other regulators are following close behind.

Read insight
Webinar

UDI Beyond Borders

12th annual UDI Conference will be hosted by USDM Life Sciences and moderated by Jay Crowley, the original developer and author of the FDA’s UDI requirements.

Read insight
Blog

The Evolving Global Medical Device Data Imperative

Device manufacturers are facing complex challenges when it comes to assessing, planning, and executing UDI regulations.

Read insight
Blog

The Origins of UDI

In this are article, we tell the story of the Unique Device Identification (UDI) System regulation.

Read insight
Blog

The Evolving Global UDI Landscape

We also realized very early on that the ultimate objective was not a US based UDI system but rather a GLOBAL system. Learn about the global UDI system effects!

Read insight
Webinar

UDI Registration in EUDAMED – Why and How to Use It Now

Learn about EUDAMED's new UDI Database module, MDR compliance, actor registration, and future steps in this expert-led discussion. Watch the webinar now!

Read insight